Crixivan and Cellulitis - a phase IV clinical study of FDA data

Summary:

Cellulitis is reported as a side effect among people who take Crixivan (indinavir sulfate), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Ativan, and have Hiv infection.

The phase IV clinical study analyzes which people have Cellulitis when taking Crixivan. It is created by eHealthMe based on reports of 6,310 people who have side effects when taking Crixivan from the FDA, and is updated regularly.

What is Crixivan?

Crixivan has active ingredients of indinavir sulfate. eHealthMe is studying from 6,312 Crixivan users. Check the latest studies of Crixivan.

What is Cellulitis?

Cellulitis (infection under the skin) is found to be associated with 2,109 drugs and 2,337 conditions by eHealthMe. Check the latest studies of Cellulitis.

On Jun, 20, 2026

6,310 people reported to have side effects when taking Crixivan.
Among them, 35 people (0.55%) have Cellulitis.

Among these 35 people:

How long have people been on Crixivan when they have Cellulitis? *

What is the gender of people who have Cellulitis when taking Crixivan? *

female: 8.57 %
male: 91.43 %

What is the age of people who have Cellulitis when taking Crixivan? *

What are other drugs people take besides Crixivan? *

What are other side effects people have besides Cellulitis? *

Oedema Lower Limb (fluid collection in tissue of lower leg): 9 people, 25.71%
Fatigue (feeling of tiredness): 9 people, 25.71%
Athlete's Foot (a fungal infection affecting the skin between the toes): 7 people, 20.00%
Fever: 7 people, 20.00%
Hepatitis C: 6 people, 17.14%
Haematocrit Decreased: 6 people, 17.14%
Abdominal Distension: 5 people, 14.29%
Hypoproteinaemia (too little prolactin circulating in the blood): 5 people, 14.29%
Hypertriglyceridaemia (excess of triglycerides in the blood): 5 people, 14.29%
Pain In Limb: 5 people, 14.29%

What are the existing conditions these people have? *

Hiv Infection: 7 people, 20.00%
Mycobacterium Avium Complex Infection: 4 people, 11.43%
Haemophilic Arthropathy (permanent joint disease): 4 people, 11.43%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 4 people, 11.43%
Deficiency Anaemia: 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Crixivan and have Cellulitis?

- Check whether Cellulitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Crixivan:

Crixivan (6,312 reports)

Cellulitis treatments and more:

Cellulitis (75,290 reports)

Browse all side effects of Crixivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis:

Cellulitis (2,109 drugs)

Browse all the conditions that are associated with Cellulitis:

Cellulitis (2,337 conditions)

Related publications that referenced our studies

Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on indinavir sulfate (the active ingredients of Crixivan) and Crixivan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.